Slides
Page 1
Interim reportQ3/2025 Strong uplift in profitability continues
Page 2
Agenda1.Cloetta in brief 2.Strategic priorities and financial targets3.Quarterly update4.Financials5.Q&A 2
Page 3
Northern Europe’s leading confectionery company creating joy through iconic brands for over 160 years 3 Employees(on average)2,600Countries with operations11 Profitability10.6%Operating profit margin, adj.10 Superbrands of net sales >50% Joined theScience Based Targets initiative (SBTi)in 2020 Net sales8,6SEKbn Pastilles & Gum Candy & Chocolate Pick & mix Powered by Joy All numbers are FY2024
Page 4
Investment case 4 Northern Europe’s leading confectionery company, creating joy through iconic brands for over 160 years A non-cyclical marketwith stable consumer demand outgrowing FMCG FoodBroad confectionery portfolio favoured by evolving consumer preferencesIconic brandportfolio of international Superbrands and strong local hero brands with high consumer loyalty Attractive growthopportunities in scaling of Superbrands, focused expansion beyond core markets, and excelling in marketing and innovation Attractive cash flow generation with clearupside on margin and shareholder value 2 3 4 5 8 Selective M&A to accelerate strategy of geographic presence and category expansion 6 7Committed to sustainabilityand responsible sourcing across the value chain 1
Page 5
Agenda1.Cloetta in brief 2.Strategic priorities and financial targets3.Quarterly update4.Financials5.Q&A 5
Page 6
To be the winning confectionery company, inspiring a more joyful world Our vision 6
Page 7
Strategic framework to drive profitable growth Win with our SuperbrandsGrowbeyond core marketsExcelin marketing and innovation Enhancing the operating model 1 2 3Vision Strategic priorities Further leverage people & culture Accelerator To be the winning confectionery company, inspiring a more joyful world Selective M&AEnablers 7
Page 8
Two major candy category launches this fallOn-going launchofFruity dropsand ChewitSoft Bites 8 Win with our Superbrands1 * Fruityvariant contains40% fruitjuice, fruitand licoricevariant contains35% fruitjuice No artificial coloursand flavors Vegan Tasty chew candies with surprising core TOP 10 most sold novelties in Denmark 2025 Available in 3 joyful flavours Cloetta’sbreakthroughinnovation withmorethan30% real fruitjuice*for the mostdeliciousjuicyfruittaste
Page 9
New consumers to brand and pastilles categoryVerysuccesfullimitededition launchofLäkerol Hot Pepperpastillesin the Nordics 9 Win with our Superbrands1 Limited launch targeting new consumers for both the Läkerol brandand the pastilles category +40% ofconsumersnew to the pastillescategory
Page 10
14% Our long-term financial targets >50%<1.5x3-4% Organic sales growthDividend policyNet debt /EBITDA¹Adjusted EBIT margin Previous target1-2%14% long-termAround 2.5x40-60% long-term ≥12% by 2027 10¹Net debt / EBITDA target may be temporarily exceeded in the event of acquisitions, provided there is a clear path to de-leveraging of profit after tax
Page 11
Agenda1.Cloetta in brief 2.Strategic priorities and financial targets3.Quarterly update4.Financials5.Q&A 11
Page 12
Strong uplift in profitability continues Q3/2025 •Another quarter of significant EBIT margin step-up•Strong uplift in profitability now successfully established•Regional variation in organic growth •Strong organic sales growth in the Nordic region •Short-term sales affected in the rest of Europe•Double-digit growth in the US •Inflation slowed downandaffected market dynamics•Retailers and food industry manufacturers in Europe facing food pricing pressure•Lower inflation also creates opportunities•Broad portfolio and new strategic framework provide clear path towards long-term organic growth target of 3-4%•All majormilestonesnowdeliveredin plan to morecloselyalignthe operating structureto the new strategicprioritiesand improveagility 12 SEKbn Q3Net sales+1.3% Q3Organic sales growth BrandedPick & mix-1.8%+9.4% 2.2Organic growth
Page 13
Agenda1.Cloetta in brief 2.Strategic priorities and financial targets3.Quarterly update4.Financials5.Q&A 13
Page 14
14 Year-to-date organic sales +2.2%Net sales Q3/24 +1.3% Organic growth +0.0% Structural changes -2.2% FXQ3/25 2196 2177 -0.9% Branded packaged: -1.8%Pick & mix: +9.4% 2024 +2.2% Organic growth -0.7% Structural changes -2.0% FX2025 6328 6294 -0.5% Branded packaged: -1.4%Pick & mix: +11.6% Q3/2025 YTD/2025
Page 15
Sales developmentQ3 share of net sales and organic sales growth byquarter 15 70% 30% Branded packaged products Pick & mixQ3/22Q4/22Q1/23Q2/23Q3/23Q4/23Q1/24Q2/24Q3/24Q4/24Q1/25Q3/25 10.2%6.1% 20.5%14.8%10.9%11.1%3.6%1.2%1.4%1.6%-3.4%-1.8% Q2/25 1.0% 15.7%21.0%32.7%22.4%16.4%13.6%11.7%3.4% 18.6%17.3%4.6% 21.3%9.4%
Page 16
16 Strong uplift in profitability continuesOperating profit, adjusted •Improvement driven by previous fair pricing and disciplinedcost control•Profitability further strengthened by net revenue management includingportfolio optimisation•Uplift achieved withcontinued long-term investments in Superbrands•Expectation to receive compensation forQ1 2024 quality incidentin next 6 months 58 Q3/24 -31 Vol./MixPrice/Cost -6 FXQ3/25 238 25910.8% 11.9%148 2024 -58 Vol./MixPrice/Cost -18 FX2025 652 72410.3% 11.5%YTD/2025Q3/2025
Page 17
Another quarterly profitability uplift in both segmentsOperating profit, adjusted, by segment 17 Branded packaged Pick & mix 191 1976 Q3/24var.Q3/25 47 6215 Q3/24var.Q3/25 12.0%12.9% 7.7% 9.5% 526 54519 2024var.2025 126 17953 2024var.2025 11.5%12.4% 7.2% 9.4% YTD/2025Q3/2025
Page 18
18 Q3/24 0 Items affecting comparability -10 FX -11 Net SG&AQ3/25 465 444 -2121.2% 20.4% SG&A 31 2024 -52 Items affecting comparability -27 FXNet SG&A2025 1 511 1 463-4823.9% 23.2%YTD/2025Q3/2025 Cost control and continued investments in Superbrands
Page 19
19 Strong FCF driven by improved working capitalCash flow Q3/2025 239 339141 1 Cash flow before changes in working capital Changes in working capital -41 Investments in PP&E and intangible assetsFree cash flowOther investing activities -830 Cash flow from financing activitiesCash flow for the period -490 229 211 19920 6-38 -18Q3/2024 •Strongfree cash flowdriven by working capital development on inventories and payables •YTD free cash flow exceedsSEK 0.5bn for the first time already in Q3 •Cash flow from financing activities mainly related to repayment of aSEK 800m loan
Page 20
Lowest-ever Net debt/EBITDA •Net debt/EBITDA of 1.1x remains below long-term target of 1.5x•Net debt of SEK 1.4bn decreased due to the strong cash flow in the quarter•New credit facilities agreementwas signed in September on favorableterms and lower commitments•Unutilised access to cash of SEK 2.5bn 20 Financial position 05001,0001,5002,0002,5003,000 0.00.51.01.52.02.53.0 Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3 1.5 0.1 0.91.4 1.3 0.3 UtilisedUnutilised 1.5 2.5Access to cash 2023 Net debt/EBITDA Net debt2024 2025 2022 Commercial PapersCredit FacilitiesCash
Page 21
Q&A
Page 22
Thank you.We hope the rest of your day is filled with many moments of joy! Upcoming IR events Nov 10, 2025Plant visit to Ljungsbroin Sweden (arranged by Danske Bank)Nov 12, 2025Berenberg Pan-European Discovery Conference USA Feb 4, 2026Year-end report 2025Feb 5, 2026Investor lunch in Stockholm (arranged by Danske Bank)
Page 23
Appendix
Page 24
Reported Greenfield Pro-forma excl. greenfield Other items affecting comparability Adjusted Net sales 6.294 - 6.294 - 6.294 Cost of goods sold -4.038 129 -4.167 -6 -4.161 Gross profit 2.256 129 2.127 -6 2.133 Selling expenses -866 - -866 -33 -833 General and administrative expenses -597 -4 -593 -17 -576 Operating profit 793 125 668 -56 724 Net financial items -74 -9 -65 - -65 Profit before tax 719 116 603 -56 659 Income tax -161 -29 -132 11 -143 Profit for the period 558 87 471 -45 516 Gross margin 35,8% 33,8% 33,9% Operating profit margin 12,6% 10,6% 11,5% Effective tax rate 22,4% 21,9% 21,7% Q3/2025 YtD Greenfield facility –Pro forma profit and loss YTD 24Pro forma information included to increase the comparability of financial tables. In February 2025, Cloetta announced that it will not proceed with the greenfield plant project.
Page 25
Important information •This presentation has been prepared by Cloetta AB (publ) (the “Company”) solely for use at this presentation and is furnished to you solely for your information and may not be reproduced or redistributed, in whole or in part, to any other person. The presentation does not constitute an invitation or offer to acquire, purchase or subscribe for securities. By attending the meeting where this presentation is made, or by reading the presentation slides, you agree to be bound by the following limitations.•This presentation is not for presentation or transmission into the United States or to any U.S. person, as that term is defined under Regulation S promulgated under the Securities Act of 1933, as amended. •This presentation contains various forward-looking statements that reflect management’s current views with respect to future events and financial and operational performance. The words “believe,” “expect,” “anticipate,” “intend,” “may,” “plan,” “estimate,” “should,” “could,” “aim,” “target,” “might,” or, in each case, their negative, or similar expressions identify certain of these forward-looking statements. Others can be identified from the context in which the statements are made. These forward-looking statements involve known and unknown risks, uncertainties and other factors, which are in some cases beyond the Company’s control and may cause actual results or performance to differ materially from those expressedor implied from such forward-looking statements. These risks include but are not limited to the Company’s ability to operate profitably, maintain its competitive position, to promote and improve its reputation and the awareness of the brands in its portfolio, to successfullyoperate its growth strategy and the impact of changes in pricing policies, political and regulatory developments in the markets in which the Company operates, and other risks.•The information and opinions contained in this document are provided as at the date of this presentation and are subject to change without notice.•No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, the fairness, accuracy or completeness of the information contained herein. Accordingly, none of the Company, or any of its principal shareholders or subsidiary undertakings or any of such person’s officers or employees accepts any liability whatsoever arising directly or indirectly from the use of this document. 25